Dashboard
Manage Tickers

TARA


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Watching Protara Therapeutics, Opthea Ltd....
05/09/2024 14:24:33

https://blog.tipranks.com/these-2-strong-buy-penny-stocks-could-surge-over-400-says-oppenheimer/

hc-wainwright--co-reiterates-buy-on-protara-therapeutics-maintains-23-price-target
HC Wainwright & Co. Reiterates Buy on Prot...
05/06/2024 10:42:05

HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price...

protara-therapeutics-q1-eps-097-misses-095-estimate
Protara Therapeutics Q1 EPS $(0.97) Misses...
05/02/2024 12:06:22

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate o...

alphabet-to-rally-around-14-here-are-10-top-analyst-forecasts-for-monday
Alphabet To Rally Around 14%? Here Are 10 ...
04/22/2024 12:32:56

oppenheimer-maintains-outperform-on-protara-therapeutics-raises-price-target-to-30
Oppenheimer Maintains Outperform on Protar...
04/22/2024 11:21:21

Oppenheimer analyst Leland Gershell maintains Protara Therapeutics (NASDAQ:TARA) with a Outperform and raises the price targ...

hc-wainwright--co-maintains-buy-on-protara-therapeutics-maintains-23-price-target
HC Wainwright & Co. Maintains Buy on Prota...
04/08/2024 11:15:31

HC Wainwright & Co. analyst Andrew Fein maintains Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price ...

protara-therapeutics-shares-interim-data-from-bladder-cancer-study-raises-45m-via-equity
Protara Therapeutics Shares Interim Data F...
04/05/2024 16:57:57

Explore TARA-002's data in NMIBC treatment. Discover findings from three trials, including response rates, adverse events, ...

protara-therapeutics-shares-are-trading-higher-after-the-company-announced-alignment-with-the-fda-on-a-registrational-path-forward-for-intravenous-choline-chloride-the-company-also-announced-an-oversubscribed-45-million-private-placement-financing
Protara Therapeutics shares are trading hi...
04/05/2024 12:10:57

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
04/05/2024 12:09:50

protara-therapeutics-announces-oversubscribed-45m-private-placement-financing
Protara Therapeutics Announces Oversubscri...
04/05/2024 12:05:12

Protara Therapeutics, Inc. (NASDAQ:TARA), a clinical-stage company developing transformative therapies for the treatment of can...

protara-therapeutics-announces-alignment-with-fda-on-registrational-path-forward-for-iv-choline-chloride-in-patients-dependent-on-parenteral-nutrition
Protara Therapeutics Announces Alignment W...
04/05/2024 12:03:48

hc-wainwright--co-reiterates-buy-on-protara-therapeutics-maintains-23-price-target
HC Wainwright & Co. Reiterates Buy on Prot...
03/14/2024 11:14:52

HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price...

protara-therapeutics-q4-eps-090-beats-092-estimate
Protara Therapeutics Q4 EPS $(0.90) Beats ...
03/13/2024 12:06:19

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.90) per share which beat the analyst consensus estimate of ...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
03/04/2024 21:32:25

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
12/11/2023 13:06:40

protara-therapeutics-announces-presentation-of-additional-encouraging-data-from-phase-1a-advanced-1-trial-of-tara-002-in-nmibc-at-the-24th-annual-meeting-of-the-society-of-urologic-oncology
Protara Therapeutics Announces Presentatio...
11/30/2023 13:37:00

New results from six patients with HGTa papillary tumors show five of six patients with HGRFS at Week 12Data continue to suppor...

protara-therapeutics-q3-eps-087-beats-098-estimate-cash-cash-equivalents-and-investments-of-74m-as-of-september-30-2023-expected-to-fund-operations-into-q2-of-2025
Protara Therapeutics Q3 EPS $(0.87) Beats ...
11/03/2023 12:14:17

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.87) per share which beat the analyst consensus estimate of ...

protara-therapeutics-announces-dosing-of-first-patient-in-phase-2-starborn-1-trial-of-tara-002-in-pediatric-patients-with-lymphatic-malformations
Protara Therapeutics Announces Dosing Of F...
10/23/2023 12:06:20

stocks-that-hit-52-week-lows-on-tuesday
Stocks That Hit 52-Week Lows On Tuesday
10/03/2023 18:37:58

  On Tuesday, 647 companies set new 52-week lows.

stocks-that-hit-52-week-lows-on-monday
Stocks That Hit 52-Week Lows On Monday
10/02/2023 17:00:10

  On Monday, 369 companies set new 52-week lows.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)